Great West Life Assurance CO Madrigal Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 1,289 shares of MDGL stock, worth $435,965. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,289
Previous 982
31.26%
Holding current value
$435,965
Previous $262,000
37.79%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MDGL
# of Institutions
294Shares Held
21.8MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$841 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$695 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$668 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$648 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$626 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.78B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...